Pinnacle Financial Partners (Georgia)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
19,742
-1,012
-5% -$152K 0.02% 408
2026
Q1
$3.17M Sell
20,754
-483
-2% -$74K 0.02% 383
2025
Q4
$2.93M Buy
+21,237
New +$2.78M 0.02% 390

Other funds holding NVS

Pinnacle Financial Partners (Georgia)'s NVS Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its Novartis (NVS) stake by 4.9% in Q2 2026, selling an estimated $152K and leaving 19,742 shares worth $3.09M. The position accounts for 0.02% of the portfolio, ranked #408.

Pinnacle Financial Partners (Georgia) first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.17M in Q1 2026. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 19,742 shares of Novartis worth $3.09M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 1,012 Novartis shares in Q2 2026, an estimated $152K.
  • Novartis made up 0.02% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #408 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s Novartis position peaked at $3.17M in Q1 2026.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.